Agenda
Arrival & Opening
Breakfast, welcome, opening remarks
8:00 – 9:00 AM
Arrival & Opening
Breakfast, welcome, opening remarks
8:00 AM – 8:45 AM
45 min
BREAKFAST, REGISTRATION, POSTER SET-UP
Networking + poster set-up before programming begins
8:45 AM – 9:00 AM
15 min
Welcome & Opening Remarks
Welcome & Land Acknowledgement — Akshita Vincent, Director, Strategy and Partnerships, PRiME
Opening Remarks
PRiME and Precision Medicine — Molly Shoichet, PRiME Scientific Director, University Professor and Pamela & Paul Austin Chair in Precision & Regenerative Medicine
MORNING SESSION I: Foundations of Precision Medicine: Drug Screening & Computational discovery
Session Chair: Molly Shoichet
9:00 – 11:00 AM
MORNING SESSION I: Foundations of Precision Medicine: Drug Screening & Computational discovery
Session Chair: Molly Shoichet
9:00 – 9:45 AM
35 min + 10 min Q&A
Scientific Keynote
Implementing functional precision oncology in interventional trials and clinical routine
Berend Snijder, Group Leader, Botnar Institute of Immune Engineering and ETH Zürich
9:50 – 10:10 AM
15 min + 5 min Q&A
Turning Wnt On to Treat Blindness: From Idea to Clinical Reality
Stephane Angers, Charles H. Best Chair of Medical Research, Professor and Director Donnelly Centre for Cellular + Biomolecular Research and Department of Biochemistry, Temerty Faculty of Medicine, University of Toronto
10:15 – 10:35 AM
15 min + 5 min Q&A
Machine learning approaches for peptide self-driving discovery
Joseph Brown, Assistant Professor, Leslie Dan Faculty of Pharmacy, University of Toronto; Faculty Advisor, Medicinal Chemistry Self-Driving Lab, Acceleration Consortium
10:35 – 11:00 AM
25 min
COFFEE BREAK & POSTERS
Refreshments + poster viewing
MORNING SESSION II: Innovating the Toolkit: Emerging modalities in Precision Medicine
Session Chair: TBC
11:00 AM – 12:00 PM
MORNING SESSION II: Innovating the Toolkit: Emerging modalities in Precision Medicine
Session Chair: TBC
11:00 – 11:45 AM
35 min + 10 min Q&A
Scientific Keynote (Title TBC)
Talk title TBC
Shana Kelley, President, Chan Zuckerberg Biohub, Chicago & Neena B. Schwartz Professor of Chemistry and Biomedical Engineering, Northwestern University
11:50 – 11:10 AM
15 min + 5 min Q&A
Talk title TBC
Milica Radisic — Founder, Quthero & Professor and Canada Research Chair Functional Cardiovascular Tissue Engineering, University of Toronto
11:15 – 11:35 AM
15 min + 5 min Q&A
The Future of Drug Discovery Through Digital Twins of Human Organs
Andrew Sage, Assistant Scientist, Toronto General Hospital Research Institute, University Health Network & Assistant Professor, Department of Surgery, Temerty Faculty of Medicine, University of Toronto
11:40 – 11:55 AM
15 min (5 talks, 3 min each)
LIGHTNING TALKS BY 2025 PRiME FELLOWS
• Maryam Ali (University of Toronto Mississauga & Leslie Dan Faculty of Pharmacy)
• Ruilin Wu (UHN & University of Toronto)
• Sathishkumar Narayanaswamy (University of Toronto & SickKids)
• Yuxi Xiao (SickKids & University of Toronto)
• Lily Takeuchi (University of Toronto & UHN)
12:00 – 1:30 PM
90 min
LUNCH & POSTERS
Refreshments + poster viewing
AFTERNOON SESSION I: Enabling Tomorrow’s Therapies: Gene Editing Platforms
Session Chair: TBC
1:35 – 4:00 PM
AFTERNOON SESSION I: Enabling Tomorrow’s Therapies: Gene Editing Platforms
Session Chair: TBC
1:35 – 2:20 PM
35 min + 10 min Q&A
Industry Keynote
Accelerating Innovation: Insights from a First-Time Founder
Alberto Nobili, Vice President & Head, Bayer Co.Lab Cambridge
2:25 – 2:45 PM
15 min + 5 min Q&A
From astrocytes to repair: Advancing innovative gene therapies to treat neurological disorders
Cindi Morshead, Professor and Chair, Division of Anatomy, Department of Surgery, University of Toronto & Professor, Institute of Biomedical Engineering
2:50 – 3:10 AM
15 min + 5 min Q&A
Subcellular organization of genetic code interpretation in neurodevelopmental disorders
Haissi Cui, Assistant Professor, Department Chemistry, University of Toronto
3:15 – 3:35 PM
15 min + 5 min Q&A
Editing Gene Expression: Synthetic Receptors, Programmable Promoters, and Therapeutic Precision for Gene and Cell Therapy Development
Michael J Garton, Associate Professor, Canada Research Chair in Synthetic Biology, Institute of Biomedical Engineering, University of Toronto
3:35 – 4:00 PM
25 min
COFFEE BREAK & POSTERS
Refreshments + poster viewing
AFTERNOON SESSION II: Translation to Impact: Industry Perspectives & Innovation Pathways
4:00 – 6:00 PM
AFTERNOON SESSION II: Translation to Impact: Industry Perspectives & Innovation Pathways
4:00 – 4:40 PM
40 min
Industry Fireside Chat
Spotlight on Innovation: Steering Next-Generation Platforms from Concept to Clinic
Panelists
Philip Kim — CTO, Co-founder, Fable Therapeutics; Professor, Canada Research Chair Tier 1, University of Toronto
Jennifer Moody — Vice President, External Innovation, LS Omics Solutions Group
Julie Audet — CEO, Co-founder, boutIQ Solutions Inc.; Professor, Biomedical Engineering, University of Toronto
Alberto Nobili — Vice President & Head, Bayer Co.Lab Cambridge
Jennifer Moody — Vice President, External Innovation, LS Omics Solutions Group
Julie Audet — CEO, Co-founder, boutIQ Solutions Inc.; Professor, Biomedical Engineering, University of Toronto
Alberto Nobili — Vice President & Head, Bayer Co.Lab Cambridge
Moderator
Leah Cowen — Vice-President, Research and Innovation, and Strategic Initiatives; Professor, Department of Molecular Genetics, Temerty Faculty of Medicine; CSO, Co-founder, Bright Angel Therapeutics
4:45 – 4:55 PM
10 min
AWARDS ANNOUNCEMENT
Carolyn Cummins, PRiME Associate Scientific Director & Associate Professor, Leslie Dan Faculty of Pharmacy, University of Toronto
4:55 – 5:05 PM
10 min
THANK YOU & CLOSING REMARKS
5:05 – 6:00 PM
50 min
NETWORKING RECEPTION
Refreshments + poster viewing